Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma.
J Immunother
; 45(8): 374-378, 2022 10 01.
Article
in En
| MEDLINE
| ID: mdl-35943386
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chordoma
/
Antineoplastic Agents, Immunological
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos